About 1 Trademarks found for “ENTOMOPHARM”

Pharmaceutical and veterinary preparations for use in BBB (blood-brain barrier) modules to determine the biomembrane permeability for the treatment of depression, schizophrenia, chronic pain, epilepsy, cancer, spinal cord trauma, neurological diseases, Huntington's disease, blood-brain barrier related malfunctions, obesity, fungal infections, A.L.S., multiple sclerosis, neuro-AIDS, namely, progressive multifocal leukoenceplalopathy (PML), autism, lysosomal storage disorders, fragile X syndrome, inherited mental retardation, inherited ataxias, prion disease, meningitis, neuromyelitis optica, late-stage neurological trypanosomiasis, parasitic diseases, De Vivo disease, rabies, encephalitis, locked-in syndrome, bacterial infections; sanitary preparations for medical purposes for the treatment of depression, schizophrenia, chronic pain, epilepsy, cancer, spinal cord trauma, neurological diseases, Huntington's disease, blood-brain barrier related malfunctions, obesity, fungal infections, A.L.S., multiple sclerosis, neuro-AIDS, namely, progressive multifocal leukoenceplalopathy (PML), autism, lysosomal storage disorders, fragile X syndrome, inherited mental retardation, inherited ataxias, prion disease, meningitis, neuromyelitis optica, late-stage neurological trypanosomiasis, parasitic diseases, De Vivo disease, rabies, encephalitis, locked-in syndrome, bacterial infections; dietetic substances, namely small molecules, nanoparticles and peptides, adapted for medical use for the treatment of depression, schizophrenia, chronic pain, epilepsy, cancer, spinal cord trauma, neurological diseases, Huntington's disease, blood-brain barrier related malfunctions, obesity, fungal infections, A.L.S., multiple sclerosis, neuro-AIDS, namely, progressive multifocal leukoenceplalopathy (PML), autism, lysosomal storage disorders, fragile X syndrome, inherited mental retardation, inherited ataxias, prion disease, meningitis, neuromyelitis optica, late-stage neurological trypanosomiasis, parasitic diseases, De Vivo disease, rabies, encephalitis, locked-in syndrome, bacterial infections, food for babies; plasters, materials for dressings, namely gauzes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Scientific and technological services in the field of new drug discovery, research and design relating thereto in the field of new drug discovery; industrial analysis and research services in the field of new drug discovery; design and development of computer hardware and software; veterinary services; horticulture services.